iPro-Care (Staging) Application icon

iPro-Care (Staging) Varies with device

1 MB / 0+ Downloads / Rating 5.0 - 1 reviews


See previous versions

iPro-Care (Staging), developed and published by You_Source, has released its latest version, Varies with device, on 2022-12-06. This app falls under the Medical category on the Google Play Store and has achieved over 1 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

iPro-Care (Staging) APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.fouriemedical.iprocarestaging

Updated: 2 years ago

Developer Name: You_Source

Category: Medical

Installation Instructions

This article outlines two straightforward methods for installing iPro-Care (Staging) on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

iPro-Care (Staging) Varies with device
2022-12-06 / 1 MB / Android 2.3+

About this app

iPro-Care helps with monitoring of patients dealing with prostate disease. This includes ongoing monitoring of the patients’ PSA levels and recalls. Ongoing monitoring leads to an increase in the number of patient visits resulting in a greater financial burden on those involved.

The purpose of this product is to reduce the number of patient visits, improve cancer care (more specifically with Prostate Cancer) and diagnosis as well as reduce the number of outpatient visits. Using the patient's results and information to monitor the PSA levels of the patient, and thereby determine when it is necessary for a patient to consult a practitioner.